Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

509 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
Loeb S, Berglund A, Stattin P. Loeb S, et al. J Urol. 2013 Nov;190(5):1742-9. doi: 10.1016/j.juro.2013.05.054. Epub 2013 May 30. J Urol. 2013. PMID: 23727309
Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography.
Loeb S, Han M, Roehl KA, Antenor JA, Catalona WJ. Loeb S, et al. J Urol. 2005 Jan;173(1):63-5. doi: 10.1097/01.ju.0000145883.01068.5f. J Urol. 2005. PMID: 15592029
The PSA era is not over for prostate cancer.
Catalona WJ, Loeb S. Catalona WJ, et al. Among authors: loeb s. Eur Urol. 2005 Oct;48(4):541-5. doi: 10.1016/j.eururo.2005.07.014. Eur Urol. 2005. PMID: 16139417 Review. No abstract available.
Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.
Nadler RB, Loeb S, Roehl KA, Antenor JA, Eggener S, Catalona WJ. Nadler RB, et al. Among authors: loeb s. J Urol. 2005 Dec;174(6):2154-7, discussion 2157. doi: 10.1097/01.ju.0000181213.07447.8f. J Urol. 2005. PMID: 16280754
Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.
Loeb S, Roehl KA, Antenor JA, Catalona WJ, Suarez BK, Nadler RB. Loeb S, et al. Urology. 2006 Feb;67(2):316-20. doi: 10.1016/j.urology.2005.08.040. Epub 2006 Jan 25. Urology. 2006. PMID: 16442597
Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.
Loeb S, Gonzalez CM, Roehl KA, Han M, Antenor JA, Yap RL, Catalona WJ. Loeb S, et al. J Urol. 2006 Mar;175(3 Pt 1):902-6. doi: 10.1016/S0022-5347(05)00327-7. J Urol. 2006. PMID: 16469576
A prospective study of laparoscopic radical nephrectomy for T1 tumors--is transperitoneal, retroperitoneal or hand assisted the best approach?
Nadler RB, Loeb S, Clemens JQ, Batler RA, Gonzalez CM, Vardi IY. Nadler RB, et al. Among authors: loeb s. J Urol. 2006 Apr;175(4):1230-3; discussion 1234. doi: 10.1016/S0022-5347(05)00686-5. J Urol. 2006. PMID: 16515966 Clinical Trial.
Viewpoint: expanding prostate cancer screening.
Catalona WJ, Loeb S, Han M. Catalona WJ, et al. Among authors: loeb s. Ann Intern Med. 2006 Mar 21;144(6):441-3. doi: 10.7326/0003-4819-144-6-200603210-00012. Ann Intern Med. 2006. PMID: 16549857
Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.
Loeb S, Roehl KA, Yu X, Antenor JA, Han M, Gashti SN, Yang XJ, Catalona WJ. Loeb S, et al. Urology. 2006 Jul;68(1):99-103. doi: 10.1016/j.urology.2006.02.004. Epub 2006 Jun 27. Urology. 2006. PMID: 16806410
Use of BioGlue in laparoscopic partial nephrectomy.
Nadler RB, Loeb S, Rubenstein RA, Vardi IY. Nadler RB, et al. Among authors: loeb s. Urology. 2006 Aug;68(2):416-8. doi: 10.1016/j.urology.2006.02.038. Urology. 2006. PMID: 16904466
509 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page